153 related articles for article (PubMed ID: 14969343)
21. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
[TBL] [Abstract][Full Text] [Related]
22. Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide).
Bodley AL; Huang HC; Yu C; Liu LF
Mol Cell Biol; 1993 Oct; 13(10):6190-200. PubMed ID: 8413219
[TBL] [Abstract][Full Text] [Related]
23. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.
Minford J; Pommier Y; Filipski J; Kohn KW; Kerrigan D; Mattern M; Michaels S; Schwartz R; Zwelling LA
Biochemistry; 1986 Jan; 25(1):9-16. PubMed ID: 3006754
[TBL] [Abstract][Full Text] [Related]
24. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
Thielmann HW; Popanda O; Gersbach H; Gilberg F
Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
[TBL] [Abstract][Full Text] [Related]
25. 2070-DTI, a topoisomerase inhibitor produced by Streptomyces sp. strain No. 2070.
Suzuki K; Doi S; Yahara S; Uyeda M
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):497-503. PubMed ID: 15008514
[TBL] [Abstract][Full Text] [Related]
26. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
Yang L; Rowe TC; Liu LF
Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763
[TBL] [Abstract][Full Text] [Related]
27. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
Snapka RM
Mol Cell Biol; 1986 Dec; 6(12):4221-7. PubMed ID: 3025645
[TBL] [Abstract][Full Text] [Related]
28. DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides.
Smith PJ; Blunt NJ; Desnoyers R; Giles Y; Patterson LH
Cancer Chemother Pharmacol; 1997; 39(5):455-61. PubMed ID: 9054961
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
Beck WT; Danks MK
Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes.
Jaxel C; Taudou G; Portemer C; Mirambeau G; Panijel J; Duguet M
Biochemistry; 1988 Jan; 27(1):95-9. PubMed ID: 2831966
[TBL] [Abstract][Full Text] [Related]
31. Efficient induction of chromosome-type aberrations by topoisomerase II inhibitors closely associated with stabilization of the cleavable complex in cultured fibroblastic cells.
Suzuki H; Ikeda T; Yamagishi T; Nakaike S; Nakane S; Ohsawa M
Mutat Res; 1995 May; 328(2):151-61. PubMed ID: 7739599
[TBL] [Abstract][Full Text] [Related]
32. The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
Musk SR; Steel GG
Br J Cancer; 1990 Sep; 62(3):364-7. PubMed ID: 2169851
[TBL] [Abstract][Full Text] [Related]
33. Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines.
Brown GA; McPherson JP; Gu L; Hedley DW; Toso R; Deuchars KL; Freedman MH; Goldenberg GJ
Cancer Res; 1995 Jan; 55(1):78-82. PubMed ID: 7805045
[TBL] [Abstract][Full Text] [Related]
34. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
Larsen AK; Grondard L; Couprie J; Desoize B; Comoe L; Jardillier JC; Riou JF
Biochem Pharmacol; 1993 Oct; 46(8):1403-12. PubMed ID: 8240389
[TBL] [Abstract][Full Text] [Related]
35. Macrostatin, a novel macromolecular inhibitor of topoisomerases produced by Streptomyces avermitilis no. C-127.
Suzuki K; Sekimoto J; Siddique T; Kamiya A; Uyeda M
J Enzyme Inhib; 1998; 14(1):69-83. PubMed ID: 10520760
[TBL] [Abstract][Full Text] [Related]
36. Differential in vitro interactions of a series of clinically useful topoisomerase-interacting compounds with the cleavage/religation activity of the human topoisomerase IIalpha and IIbeta isoforms.
van Hille B; Perrin D; Hill BT
Anticancer Drugs; 1999 Jul; 10(6):551-60. PubMed ID: 10885903
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermia, thermotolerance and topoisomerase II inhibitors.
Kampinga HH
Br J Cancer; 1995 Aug; 72(2):333-8. PubMed ID: 7640214
[TBL] [Abstract][Full Text] [Related]
38. Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site.
Hasinoff BB; Creighton AM; Kozlowska H; Thampatty P; Allan WP; Yalowich JC
Mol Pharmacol; 1997 Nov; 52(5):839-45. PubMed ID: 9351975
[TBL] [Abstract][Full Text] [Related]
39. The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis.
Hasinoff BB; Chee GL; Thampatty P; Allan WP; Yalowich JC
Anticancer Drugs; 1999 Jan; 10(1):47-54. PubMed ID: 10194547
[TBL] [Abstract][Full Text] [Related]
40. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
Báez A; Riou JF; Le Pecq JB; Riou G
Mol Pharmacol; 1990 Mar; 37(3):377-82. PubMed ID: 2156151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]